Cardiosel OD
Formulation
Each film-coated extended release tablet contains:  
Metoprolol succinate

(Equivalent to Metoprolol tartrate 50 mg)

47.5 mg

Metoprolol succinate

Cardiosel® OD

Prescription Drug

Indication

  • Hypertension: As monotherapy or in combination with other antihypertensive agents
  • Pediatric hypertension
  • Angina pectoris: Long-term prophylaxis
  • Cardiac arrhythmias: Disturbances of cardiac rhythm, including supraventricular tachycardia, reduction of ventricular rate in atrial fibrillation and ventricular extrasystoles
  • Myocardial infarction (MI): Maintenance treatment after MI
  • Functional heart disorders with palpitations
  • Hyperthyroidism
  • Prophylaxis of migraine headache

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Information Leaflet.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.